Priority from the Bleeding Disorder PSP
| UNCERTAINTY: When is treatment for immune thrombocytopenic purpura (ITP) required? | |
|---|---|
| Overall ranking | This was one of the 15 questions at the workshop that fell outside of the Top 10. These were not ranked in any order of priority |
| JLA question ID | 0078/18 |
| Explanatory note | All the treatments for ITP have some kind of side effects and so should be used only when needed. We do not know at what level of platelet count the benefits outweigh the risks. |
| Evidence | No systematic reviews identified |
| Health Research Classification System category | Blood |
| Extra information provided by this PSP | |
|---|---|
| Original uncertainty examples | Not available |
| Submitted by | Not available |
| PSP information | |
|---|---|
| PSP unique ID | 0078 |
| PSP name | Bleeding Disorders |
| Total number of uncertainties identified by this PSP. | 66 (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website) |
| Date of priority setting workshop | 7 July 2018 |